Active Stocks

Thu Jun 26 2025 15:58:52

Tata Steel share price
160.50 2.62%

Bajaj Finance share price
951.45 2.50%

Tata Motors share price
683.00 1.28%

State Bank Of India share price
797.00 -0.39%

Reliance Industries share price
1,495.20 1.90%

Business News > Mint Authors > Jessica Jani

Jessica Jani

Correspondent

Jessica is a correspondent at Mint. She writes on everything pharma, healthcare and lifesciences.

ARTICLES BY JESSICA JANI

Executive chairperson of Apollo HealthCo Shobana Kamineni says our growth is measured, but healthy.

Apollo HealthCo to be ₹30,000 crore company in 5-6 yrs, says Shobana Kamineni

4 min read . 07:07 PM IST

Mounjaro is currently priced at ₹14,000 monthly for a 2.5 mg vial and ₹17,500 monthly for the 5 mg version. (Photo: Reuters)

Eli Lilly to launch pen version of weight-loss drug Mounjaro in India

2 min read . 03:41 PM IST

Wegovy by Novo Nordisk is a once-a-week injection that follows a monthly dosage cycle. (REUTERS)

Novo Nordisk launches weight loss drug Wegovy priced at ₹17,345 per month

2 min read . 24 Jun 2025

Novo Nordisk is preparing to launch Wegovy in India, where millions of people are battling obesity and demand for the weight-loss drug is expected to be massive.

Novo Nordisk preparing to launch weight-loss drug Wegovy in India

5 min read . 24 Jun 2025

While the healthcare foray is in line with Amazon’s global strategy, India is the only country which has diagnostics services currently.

Amazon brings diagnostic test booking to app

2 min read . 22 Jun 2025

A recent Lancet study stated that India is expected to total 450 million overweight or obese people by 2050, the largest in the world. (Tarun Kumar Sahu/Mint)

Ozempic, a patent challenge, and $25 bn race for India’s weight-loss drug market

10 min read . 19 Jun 2025

Biocon launches QIP to raise ₹4,500 crore

2 min read . 17 Jun 2025

Kirti Ganorkar will succeed founder Dilip Shanghvi as managing director

Sun Pharma names Kirti Ganorkar as new managing director

2 min read . 13 Jun 2025

CitiusTech CEO Rajan Kohli said that the company will evaluate listing in either India or the US. (CitiusTech)

Bain Capital-backed CitiusTech exploring acquisitions, to evaluate IPO

2 min read . 13 Jun 2025

Advent bets $175 million on Felix Pharma to tap rising demand for generic animal health drug, (Image: Pixabay)

Advent to invest $175 million in Felix Pharma’s animal generics business

2 min read . 09 Jun 2025

Medikabazaar CEO Dinesh Lodha told Mint the startup has started exports and is expanding its portfolio offerings to drive growth.

How Medikabazaar's CEO is trying to turn around the business, become profitable

4 min read . 05 Jun 2025

Zydus Lifesciences managing director Sharvil Patel.

Zydus buys Agenus' biologics plants in US for $125 mn, licenses cancer therapy

3 min read . 03 Jun 2025

The market for multiple myeloma is projected to grow to about $33 billion by 2030, according to estimates by Bloomberg Intelligence. (Image: Pixabay)

Glenmark-Ichnos cancer drug shows 74% response in phase-1 trial

2 min read . 02 Jun 2025

Ranjan Pai, chairman of the Manipal Education and Medical Group (or the Manipal Group). (Aniruddha Chowdhury/Mint)

KKR provides $600 mn financing to Manipal Group to fuel its corporate expansion

2 min read . 02 Jun 2025

Vidhi Shanghvi heads Sun Pharma's consumer healthcare business. (Photo via X (Twitter))

Young heirs take charge as Indian pharma firms plan succession

5 min read . 01 Jun 2025

Apollo Hospitals Enterprise has approved a brownfield expansion of 160 beds across Jubilee Hills and Secunderabad facilities in Hyderabad. (Pixabay)

Apollo Hospitals to deepen presence in Bengaluru, Hyderabad

2 min read . 30 May 2025

Mankind is developing a novel anti-obesity and diabetes drug in-house. (REUTERS)

Why Mankind Pharma MD Rajeev Juneja wants to deepen gastro, derma presence

4 min read . 27 May 2025

Sun Pharmaceutical plans to invest an additional $100 million on the commercialization of its new specialty product pipeline in the US. (Mint)

Sun Pharma redoubles efforts as its specialty bet is paying off

2 min read . 22 May 2025

Emcure Pharma sharpened its focus in the dermatology segment with the launch of its subsidiary, Emcutix Biopharmaceuticals. (Image: Pixabay)

Emcure Pharmaceuticals to expand gynaecology, derma portfolio in FY26

2 min read . 22 May 2025

Zydus Lifesciences managing director Sharvil Patel.

Zydus bets big on vaccines and medtech

3 min read . 21 May 2025